Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose

Therapeutic Drug Monitoring

Volumn 30, Issue 4, 2008, Pages 553-556

  Bodmer, Michael ^a   Burkard, Thilo ^a   Kummer, Oliver ^a   Beyrau, Ralf ^a   Krähenbühl, Stephan ^a   Haschke, Manuel ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antipsychotic; Overdose; Pharmacokinetics; Quetiapine; Seizure

Indexed keywords

ACTIVATED CARBON; BENZODIAZEPINE DERIVATIVE; GLUCOSE; LACTIC ACID; LORAZEPAM; PROPOFOL; QUETIAPINE; RINGER LACTATE SOLUTION; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AGGRESSION; AGITATION; ARTICLE; BLOOD; CASE REPORT; COMATOSE PATIENT; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; ENDOTRACHEAL INTUBATION; EXTUBATION; FEMALE; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; GRAND MAL SEIZURE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LEUKOCYTE; LIVER CLEARANCE; MENTAL HOSPITAL; MYOCLONUS; PATIENT TRANSPORT; PRIORITY JOURNAL; QT INTERVAL; SEDATION; SINUS TACHYCARDIA; TISSUE DISTRIBUTION; TONIC CLONIC SEIZURE; AUTONOMIC NEUROPATHY; CHEMICALLY INDUCED DISORDER; CHOLINERGIC SYSTEM; COMA; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTOXICATION; LONG QT SYNDROME; MAJOR DEPRESSION; SCHIZOPHRENIA; SEIZURE; SUICIDE ATTEMPT;

ADULT; ANTIPSYCHOTIC AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMA; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; FEMALE; GLASGOW COMA SCALE; HALF-LIFE; HUMANS; LONG QT SYNDROME; OVERDOSE; PARASYMPATHETIC NERVOUS SYSTEM; SCHIZOPHRENIA; SEIZURES; SUICIDE, ATTEMPTED;

EID: 58149140516     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31817fd5ed     Document Type: Article

References (19)

1. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet. 2001;40:509-522.
2. Isbister GK, Friberg LE, Hackett LP, et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther. 2007;81:821-827.
3. Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf. 2000;23:295-307.
4. Burns MJ. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol. 2001;39:1-14.
5. Balit CR, Isbister GK, Hackett LP, et al. Quetiapine poisoning: a case series. Ann Emerg Med. 2003;42:751-758.
6. Hunfeld NG, Westerman EM, Boswijk DJ, et al. Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit. 2006;28:185-189.
7. Nemeroff CB, Kinkead B, Goldstein J. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. J Clin Psychiatry. 2002; 63(Suppl 13):5-11.
8. Hustey FM. Acute quetiapine poisoning. J Emerg Med. 1999;17:995-997.
9. Gajwani P, Pozuelo L, Tesar GE. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics. 2000;41:63-65.
10. Pollak PT, Zbuk K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther. 2000; 68:92-97.
11. Smith RP, Puckett BN, Crawford J, et al. Quetiapine overdose and severe rhabdomyolysis. J Clin Psychopharmacol. 2004;24:343.
12. Vivek S. No QT interval prolongation associated with quetiapine overdose. Am J Emerg Med. 2004;22:330.
13. Strachan PM, Benoff BA. Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy. 2006;26:578-582.
14. Fernandes PP, MarcilWA. Death associated with quetiapine overdose. Am J Psychiatry. 2002;159:2114.
15. Harmon TJ, Benitez JG, Krenzelok EP, et al. Loss of consciousness from acute quetiapine overdosage. J Toxicol Clin Toxicol. 1998;36: 599-602.
16. Chen XH, Franke JP, Ensing K, et al. Pitfalls and solutions in the development of a fully automated solid-phase extraction method for drug screening purposes in plasma and whole blood. J Anal Toxicol. 1993;17: 421-426.
17. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-1022.
18. Velayudhan L, Kirchner V. Quetiapine-induced myoclonus. Int Clin Psychopharmacol. 2005;20:119-120.
19. Grimm SW, Richtand NM, Winter HR, et al. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol. 2006;61:58-69.